510(k) Report

510(k) · Cleared

Cleared

Cellplex TCP Synthetic Cancellous Bone

K031817510(k) SpecialCleared Jul 17, 200335-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Wrightmedicaltechnologyinc · MQV Filler, Bone Void, Calcium Compound

Cleared on Jul 17, 2003 as substantially equivalent to K022629 (Wrightmedicaltechnologyinc, 2002) and 1 other predicate after a 35-day review. Its family tree reaches back 2 generations to 2002. 52 later devices descend from it.

Decided
Jul 17, 2003
Review
35 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K013966 (2002). 3 ancestors in all, the oldest K994337 (2000). 52 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor2005: 1 descendant cleared2008: 1 descendant cleared2006: 2 descendants cleared2010: 1 descendant cleared2012: 2 descendants cleared2011: 2 descendants cleared2015: 3 descendants cleared2014: 5 descendants cleared2016: 3 descendants cleared2019: 2 descendants cleared2024: 5 descendants cleared2017: 2 descendants cleared2023: 6 descendants cleared2020: 7 descendants cleared2018: 3 descendants cleared2021: 2 descendants cleared2022: 2 descendants cleared2025: 2 descendants cleared2026: 1 descendant clearedK013966 · Apatight-TCP Bone Graft Substitute · Cerabio, LLC · 2002K022629 · WMT-TCP Bone Graft Substitute · Wrightmedicaltechnologyinc · 2002200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 4 descendants3 generations forward: 4 descendants4 generations forward: 7 descendants5 generations forward: 5 descendants6 generations forward: 9 descendants7 generations forward: 15 descendants8 generations forward: 5 descendants9 generations forward: 1 descendant10 generations forward: 1 descendant K022629 · WMT-TCP Bone Graft Substitute · Wrightmedicaltechnologyinc · 2002K013966 · Apatight-TCP Bone Graft Substitute · Cerabio, LLC · 20020+5+10
  1. Root · 2 generations backK013966 Apatight-TCP Bone Graft SubstituteCerabio, LLC · 2002
  2. 1 generation backK022629 WMT-TCP Bone Graft SubstituteWrightmedicaltechnologyinc · 2002
  3. This deviceK031817 Cellplex TCP Synthetic Cancellous BoneWrightmedicaltechnologyinc · 2003
  4. Descendant · cites it directly · 51 of its ownK043261 Harvest Graft Delivery SyringeHarvest Technologies, Corp. · 2005 · Recalled
  5. Descendant · 2 generations on · 45 of its ownK100754 Graft Delivery System Model SA-6115Micromedics, Inc. · 2010
  6. Descendant · 3 generations on · 41 of its ownK111632 Infill Graft Delivery SystemPinnacle Spine Group, LLC · 2011
  7. Descendant · 4 generations on · 40 of its ownK121476 Infill Graft Delivery SystemPinnacle Spine Group, LLC · 2012
  8. Descendant · 2 generations on · 37 of its ownK062986 Medtronic Graft Delivery SyringeMedtronic Sofamor Danek USA, Inc. · 2006

Showing 5 of 52 descendants. See all descendants

Descendants cleared per year

2005: 12006: 22008: 12010: 12011: 22012: 22014: 52015: 32016: 32017: 22018: 32019: 22020: 72021: 22022: 22023: 62024: 52025: 22026: 1
2005high 7 (2020) · low 0 (2007)2026

Most influential descendants

Showing 5 of 52 · See all
  • K043261Harvest Graft Delivery SyringeHarvest Technologies, Corp. · 2005 · cites it directly51descendants
  • K100754Graft Delivery System Model SA-6115Micromedics, Inc. · 2010 · 2 generations on45descendants
  • K111632Infill Graft Delivery SystemPinnacle Spine Group, LLC · 2011 · 3 generations on41descendants
  • K121476Infill Graft Delivery SystemPinnacle Spine Group, LLC · 2012 · 4 generations on40descendants
  • K062986Medtronic Graft Delivery SyringeMedtronic Sofamor Danek USA, Inc. · 2006 · 2 generations on37descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K013966Apatight-TCP Bone Graft SubstituteCerabio, LLC2002—
−1K022629WMT-TCP Bone Graft SubstituteWrightmedicaltechnologyinc2002—
0 (this device)K031817Cellplex TCP Synthetic Cancellous BoneWrightmedicaltechnologyinc2003—
+1K043261Harvest Graft Delivery SyringeHarvest Technologies, Corp.20052
+2K100754Graft Delivery System Model SA-6115Micromedics, Inc.2010—
+3K111632Infill Graft Delivery SystemPinnacle Spine Group, LLC2011—
+4K121476Infill Graft Delivery SystemPinnacle Spine Group, LLC2012—
+2K062986Medtronic Graft Delivery SyringeMedtronic Sofamor Danek USA, Inc.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200620
200810
201010
201120
201220
201450
201530
201630
201720
201830
201920
202070
202120
202220
202360
202450
202520
202610
FIG. 1 — Lineage of K031817, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022629WMT-TCP Bone Graft Substitute
Summary page 2
…Cancellous Bone are substantially equivalent to the intended use, material composition, and design features of the previously cleared WMT-TCP Bone Graft Substitute (K022629). The mechanical properties of the CELLPLEXTMTCP Synthetic Cancellous Bone are substantially equivalent to the VITOSSTMScaffold…
Wrightmedicaltechnologyinc2002—
*K994337Vitoss Scaffold Synthetic Cancellous Bone Void Filler
Summary page 2
…The mechanical properties of the CELLPLEXTMTCP Synthetic Cancellous Bone are substantially equivalent to the VITOSSTMScaffold Synthetic Cancellous Bone Void Filler (K994337). The safety and effectiveness of the CELLPLEXTMTCP Synthetic Cancellous Bone is adequately supported by the substantial equiva…
Orthovita Co.2000—

Also cleared against K022629: 2 other devices →

What descends from it? (52)

See all 52

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K043261Harvest Graft Delivery SyringeHarvest Technologies, Corp.200551

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 1 year and passes through 2 companies; a new generation was cleared every 8 months on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K043261 (Harvest Technologies, Corp., 2005) has gone furthest, with 51 descendants of its own.
  • 2 other devices also cite its predicate K022629.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

CELLPLEXTMTCP Synthetic Cancellous Bone can be combined with autogenous bone marrow aspirate and/or blood and is indicated for bony voids or gaps that are not intrinsic to the stability of the bony structure. The CELLPLEXTMTCP Synthetic Cancellous Bone is intended to be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K031817: Cellplex TCP Synthetic Cancellous Bone.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K031817

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026